- Home
- DNTH vs AXGN Comparison
DNTH vs AXGN Comparison
Compare DNTH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- AXGN
- Stock Information
- Founded
- DNTH 2015
- AXGN N/A
- Country
- DNTH United States
- AXGN United States
- Employees
- DNTH N/A
- AXGN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DNTH Health Care
- AXGN Health Care
- Exchange
- DNTH Nasdaq
- AXGN Nasdaq
- Market Cap
- DNTH 711.2M
- AXGN 813.6M
- IPO Year
- DNTH N/A
- AXGN N/A
- Fundamental
- Price
- DNTH $21.66
- AXGN $18.97
- Analyst Decision
- DNTH Strong Buy
- AXGN Strong Buy
- Analyst Count
- DNTH 9
- AXGN 4
- Target Price
- DNTH $46.43
- AXGN $15.00
- AVG Volume (30 Days)
- DNTH 285.9K
- AXGN 607.5K
- Earning Date
- DNTH 11-07-2024
- AXGN 03-04-2025
- Dividend Yield
- DNTH N/A
- AXGN N/A
- EPS Growth
- DNTH N/A
- AXGN N/A
- EPS
- DNTH N/A
- AXGN N/A
- Revenue
- DNTH $5,366,000.00
- AXGN $180,855,000.00
- Revenue This Year
- DNTH $100.14
- AXGN $18.91
- Revenue Next Year
- DNTH N/A
- AXGN $13.02
- P/E Ratio
- DNTH N/A
- AXGN N/A
- Revenue Growth
- DNTH 51.41
- AXGN 18.79
- 52 Week Low
- DNTH $14.82
- AXGN $5.55
- 52 Week High
- DNTH $33.77
- AXGN $18.99
- Technical
- Relative Strength Index (RSI)
- DNTH 45.12
- AXGN 67.82
- Support Level
- DNTH $18.72
- AXGN $18.02
- Resistance Level
- DNTH $28.65
- AXGN $18.96
- Average True Range (ATR)
- DNTH 2.31
- AXGN 1.21
- MACD
- DNTH -0.33
- AXGN 0.20
- Stochastic Oscillator
- DNTH 32.14
- AXGN 99.40
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.